Obagi C RX Clarifying Serum Normal to Oily

Contains 4% hydroquinone to reduce hyperpigmentation, such as dark spots and melasma, for a lighter, more even skin tone. Also contains 10% L-ascorbic acid (Vitamin C) to help defend against free radicals and address the appearance of aging skin.

Effective prescription 4% hydroquinone that helps correct hyperpigmentation, such as dark spots, sun spots, age spots, melasma, and other types of discoloration, for a healthier-looking, more even skin tone.*

This product requires a prescription which we offer for free through our telemedicine partner My Doctror’s Live. After you complete your purchase, we will reach out to you about scheduling a quick 5 minute telemedicine appointment. To learn more about My Doctor’s Live, please visit My Doctor’s Live | Totality Skincare (totality-skincare.com)

Active Ingredient:

4% Hydroquinone

Key Ingredient:
10% L-ascorbic Acid

Early Intervention for Signs of Skin Damage

With Obagi-C Rx, you’re on your way to softer, smoother, radiant, and more even-looking skin. The Obagi-C Rx System offers 4% hydroquinone to reduce hyperpigmentation, and other key ingredients that help address the signs of skin aging to maintain younger-looking skin.

Obagi-C Rx System products are ideal if you have:

• Hyperpigmentation, sun damage, and age spots

• Uneven skin tone

• Rough skin

• The appearance fine lines and wrinkles

• Dry, normal, or oily skin

Clinically Supported Ingredients

Prescription 4% hydroquinone

• Improves hyperpigmentation (brown spots)

• Provides a lighter, more even-toned complexion

Other key ingredients that address the signs of skin aging

• An exfoliator helps support skin turnover through gentle exfoliation

• 10% L-ascorbic acid (Vitamin C) helps defend against free radicals
• A broad spectrum sunscreen helps protect against harmful UVA and UVB rays

Deep Skin Absorption

When the Obagi-C Rx C-Clarifying Serum with C-Balancing Toner were compared to SkinCeuticals Phloretin CF®, another leading Vitamin C product, more Vitamin C remained in the skin at 24 hours.1,*

*Based on in vitro studies. Clinical significance has not been established.

Reference: 1. Lehman PA, Investigator, Cetero Research. Evaluation of the percutaneous absorption of 14C-ascorbic acid, in vitro, using the Franz human skin finite dose model (protocol R09-0715). Data on file.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.